XSTOADDV B
Market cap60mUSD
Dec 23, Last price
3.48SEK
1D
5.78%
1Q
-47.03%
Jan 2017
83.16%
Name
ADDvise Group AB (publ)
Chart & Performance
Profile
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The company's Lab business unit designs, manufactures, and sells clean room systems and safety ventilation to laboratories, and scales to the research, industrial and grocery sectors. It is also involved in sale of equipment to laboratories, including centrifuges, water baths, and environmental chambers, and service and maintenance of scales, laboratory equipment, and storage of products. Its Healthcare business unit engages in the design, manufacture, and sale of the surgical tables, healthcare, and safety products, medtech cables, connection systems, orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. This segment also offers sale of consumable materials for healthcare, ultrasound systems, radiographic equipment, and examination tables for urology and gynecology. In addition, the company supplies laboratory furnishings and apparatus. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,373,000 44.30% | 951,521 104.21% | 465,953 29.98% | |||||||
Cost of revenue | 479,500 | 559,256 | 299,705 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 893,500 | 392,265 | 166,248 | |||||||
NOPBT Margin | 65.08% | 41.23% | 35.68% | |||||||
Operating Taxes | 60,800 | 26,888 | 4,853 | |||||||
Tax Rate | 6.80% | 6.85% | 2.92% | |||||||
NOPAT | 832,700 | 365,377 | 161,395 | |||||||
Net income | 103,500 27.62% | 81,100 2,791.27% | 2,805 -80.84% | |||||||
Dividends | (2,794) | |||||||||
Dividend yield | 0.22% | |||||||||
Proceeds from repurchase of equity | 100,000 | 100,000 | 152,811 | |||||||
BB yield | -3.95% | -7.62% | -12.13% | |||||||
Debt | ||||||||||
Debt current | 90,000 | 33,544 | 29,044 | |||||||
Long-term debt | 1,614,500 | 820,983 | 561,645 | |||||||
Deferred revenue | 300 | 449 | ||||||||
Other long-term liabilities | 288,700 | 227,143 | 108,024 | |||||||
Net debt | 1,318,000 | 728,721 | 250,603 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 175,000 | 109,876 | 10,186 | |||||||
CAPEX | (9,200) | (13,962) | (4,137) | |||||||
Cash from investing activities | (684,900) | (638,587) | (201,662) | |||||||
Cash from financing activities | 783,500 | 303,018 | 473,975 | |||||||
FCF | 831,526 | 313,814 | 57,388 | |||||||
Balance | ||||||||||
Cash | 386,500 | 111,093 | 325,735 | |||||||
Long term investments | 14,713 | 14,351 | ||||||||
Excess cash | 317,850 | 78,230 | 316,788 | |||||||
Stockholders' equity | 201,600 | 175,884 | 24,169 | |||||||
Invested Capital | 2,314,000 | 1,393,975 | 875,522 | |||||||
ROIC | 44.91% | 32.20% | 28.03% | |||||||
ROCE | 33.29% | 24.88% | 18.18% | |||||||
EV | ||||||||||
Common stock shares outstanding | 185,803 | 177,457 | 143,134 | |||||||
Price | 13.64 84.32% | 7.40 -15.91% | 8.80 587.50% | |||||||
Market cap | 2,534,349 92.99% | 1,313,183 4.26% | 1,259,577 769.81% | |||||||
EV | 3,852,349 | 2,041,904 | 1,510,180 | |||||||
EBITDA | 1,002,200 | 420,197 | 176,981 | |||||||
EV/EBITDA | 3.84 | 4.86 | 8.53 | |||||||
Interest | 153,700 | 45,724 | 37,423 | |||||||
Interest/NOPBT | 17.20% | 11.66% | 22.51% |